DPP4 and cancer: The significance of the biomolecule Dipeptidyl peptidase 4/CD26 (DPP4/CD26) has been proposed in elucidating susceptibility to neoplastic growth and coronaviruses, as well as its participation in the immune response [37], implying that SCRGs may exert a substantial impact on cancer immunotherapy.